InvestorsHub Logo
Followers 155
Posts 2683
Boards Moderated 0
Alias Born 01/29/2004

Re: drv17 post# 327771

Friday, 08/27/2021 9:20:29 AM

Friday, August 27, 2021 9:20:29 AM

Post# of 470923
Tells of blarcamesine cellular salubriosity.

I am waiting for you knowledgeable posters to address this technical article from Italy that Kentucky posted yesterday.


Thanks.

But there is nothing in the article to “address,” to explain, correct, or answer for. Simply, without specifically telling how it does it, the quote broadly summarizes the multitude of salubrious effects blarcamesine has on neurons. All very good outcomes; ones that few other molecules can induce for any single outcome. Astonishing, blarcamesine does a multitude of good things.

Of course, hard to explain, until the mechanism of actions of the molecule, inside cells, is sufficiently understood. In the simplest terms, blarcamesine, when binding to the sigma-1 receptor protein, “activates” it, allowing it to then properly modulate, control, or promote all of the good “downstream” reaction sequences and processes the protein controls; which, in the end, make neurons function normally; without disease or dysfunction.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News